Yumi Asukai
Brentford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Journal: Arthritis care & research
Published: October 29, 2021
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic.
Journal: PharmacoEconomics
Published: September 02, 2021
Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study.
Journal: Lupus science & medicine
Published: May 01, 2020
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Journal: Respiratory research
Published: January 16, 2019
Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis.
Journal: Annals of the rheumatic diseases
Published: July 03, 2018
Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment.
Journal: Arthritis care & research
Published: March 16, 2018
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 13, 2016
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: September 11, 2015
Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
Journal: Applied health economics and health policy
Published: September 02, 2015
Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment Scenarios.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Last Updated: 09/26/2026